Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

545
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
545
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

3.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

711
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
711
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

2.1K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.1K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

423
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
423

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From the Emergency Department, Directly to Ablation of Atrial Fibrillation: Rationale and Design of the EMERGE Cryo Study.

CJC open·2026
Same author

Ventricular dispersion and repolarization in Marfan syndrome: A clinical analysis.

Heart rhythm O2·2025
Same author

Response to: implantable cardiac devices in cardiac sarcoidosis-it's about preventing the unforeseeable.

European heart journal. Case reports·2023
Same author

Intermittent complete atrioventricular block in a 20-year-old woman with cardiac sarcoidosis: a case report.

European heart journal. Case reports·2022
Same author

Genetic and Clinical Predictors of Left Atrial Thrombus: A Single Center Case-Control Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2021
Same author

Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2021
Same journal

[Extrasystoles in endurance athletes].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[AI-Assisted ECG diagnostics : Classical test statistics still apply].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Perioperative complications during transvenous pacemaker and defibrillator implantation].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Late complications after atrial fibrillation ablation : Diagnosis and management].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary].

Herzschrittmachertherapie & Elektrophysiologie·2026
See all related articles

Related Experiment Video

Updated: Mar 2, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K

[Emergency pharmacotherapy in rhythmology].

Boris A Hoffmann1

  • 1Klinik für Kardiologie - Rhythmologie, Asklepios Klinikum Harburg, Eißendorfer Pferdeweg 52, 21075, Hamburg, Deutschland. bo.hoffmann@asklepios.com.

Herzschrittmachertherapie & Elektrophysiologie
|March 1, 2026
PubMed
Summary
This summary is machine-generated.

Rapid pharmacotherapy is crucial for acute cardiac arrhythmias, including ventricular tachyarrhythmias. Established and specific antiarrhythmic drugs are vital for preventing hemodynamic instability and mortality in emergency cardiac electrophysiology.

Keywords:
Antiarrhythmic drugsAtrial fibrillationBradycardiaSupraventricular tachycardiaVentricular tachycardia

More Related Videos

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.2K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K

Related Experiment Videos

Last Updated: Mar 2, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.2K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K

Area of Science:

  • Clinical Cardiac Electrophysiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute cardiac arrhythmias are common and prognostically significant emergencies.
  • Arrhythmias range from bradycardia and supraventricular tachycardia to life-threatening ventricular tachyarrhythmias and electrical storm.
  • Rapid, structured, and guideline-based pharmacotherapy is essential to prevent hemodynamic instability and mortality.

Purpose of the Study:

  • To review the essential pharmacotherapy for acute cardiac arrhythmias.
  • To highlight the importance of established antiarrhythmic drugs in emergency settings.
  • To discuss the role of specific agents in complex ventricular arrhythmias.

Main Methods:

  • Review of current clinical practices and literature on acute arrhythmia management.
  • Analysis of drug selection criteria based on arrhythmia type, hemodynamic status, and patient factors.
  • Discussion of established and less common antiarrhythmic agents.

Main Results:

  • Selection of emergency medication depends on arrhythmia, hemodynamics, and patient factors.
  • Classical antiarrhythmic drugs, AV nodal agents, beta-blockers, calcium channel blockers, adenosine, glycosides, and catecholamines are key.
  • Established drugs remain important due to lack of new approvals; procainamide and mexiletine are considered for complex ventricular arrhythmias.

Conclusions:

  • Effective management of acute cardiac arrhythmias relies on appropriate pharmacotherapy.
  • Established antiarrhythmic drugs are cornerstones of emergency treatment.
  • Specialized agents may be crucial for refractory or complex ventricular arrhythmias.